Morgan Stanley Maintains Overweight on Everpure, Raises Price Target to $119

Benzinga Newsdesk www.benzinga.com Positive 77.5%

Neg 0% Neu 0% Pos 77.5%

Morgan Stanley analyst Benjamin Swinburne maintains Everpure (NYSE:P) with a Overweight and raises the price target from $108 to $119.